Federal Rescheduling to Schedule III and the Emerging State Reckoning: South Carolina’s Statutory Trigger, Tennessee’s Legislative Blockade, and the Intellectual Lineage of Schedule I Nullification from Judge Francis L. Young’s 1988 Ruling Through Iowa Activism to Michigan Dismissals

Marijuana, in its natural form, is one of the safest therapeutically active substances known to man. It would be unreasonable, arbitrary and capricious for the DEA to continue to stand between those sufferers and the benefits of this substance.¹²

Why South Dakota’s Own Statutes Now Make Schedule I Marijuana Unlawful to Maintain

The Department of Justice announced on April 23, 2026, the issuance of a final order immediately placing FDA-approved drug products containing marijuana and marijuana products subject to qualifying state medical marijuana licenses in Schedule III of the federal Controlled Substances Act (CSA). The final rule was published in the Federal Register on April 28, 2026, and became effective upon publication.¹ As anticipated in these pages more than sixteen months ago, at least twenty-seven states maintain statutory mechanisms that automatically align their controlled-substance schedules with federal changes absent affirmative legislative intervention.² That prediction—published December 16, 2024—is now materializing with precision.

In South Carolina, S.C. Code Ann. § 44-53-160(C) mandates that the Department of Public Health reschedule any substance “within thirty days after publication in the Federal Register of the final order” adding, deleting, or rescheduling a controlled substance under federal law.³ The Marijuana Moment report of April 29, 2026, details how this “little-known” trigger could unlock medical-marijuana access for patients without further legislative action, prompting State Sen. Tom Davis (R) to observe that the General Assembly “can no longer ignore” the chain of legal consequences.⁴ Governor Henry McMaster’s office has confirmed awareness of the mirroring obligation.⁵

Tennessee moved preemptively to insulate itself from the same automaticity. On April 23, 2026—the same day the federal order issued—Governor Bill Lee signed SB 1603 (2026), which strips the commissioner of mental health and substance abuse services of authority to reschedule marijuana to conform with federal law unless the General Assembly first creates a regulatory framework.⁶ The legislation was expressly designed to avoid the South Carolina scenario, preserving legislative prerogative over what had been an administrative trigger under prior Tennessee Code Annotated § 39-17-403.⁷

These contemporaneous developments validate the granular statutory mapping published on WeedPress.org in December 2024.⁸ The article catalogued the precise language in twenty-seven jurisdictions—Alaska through Wyoming—where federal rescheduling would operate as a self-executing directive on state schedules.⁹ The pattern is clear: cooperative federalism under the CSA is not merely aspirational; in many states it is statutorily compelled.

The Intellectual Foundations: From Judge Francis L. Young’s 1988 Recommended Ruling to Contemporary Schedule I Challenges

Any serious examination of these scheduling dynamics must return to the foundational 1988 administrative record. In In re Marijuana Rescheduling Petition, DEA Docket No. 86-22, Chief Administrative Law Judge Francis L. Young presided over extensive hearings on petitions filed by the National Organization for the Reform of Marijuana Laws (NORML), the Alliance for Cannabis Therapeutics (ACT), the Cannabis Corporation of America (CCA), and Iowa activist Carl Eric Olsen, appearing pro se.¹⁰ The Federal Register and the opinion itself confirm these parties as the pro-rescheduling petitioners.¹¹

After reviewing thousands of pages of testimony and exhibits, Judge Young issued a meticulously reasoned Opinion and Recommended Ruling on September 6, 1988. He concluded that marijuana in its natural form did not meet the statutory criteria for Schedule I under 21 U.S.C. § 812(b)(1). Specifically, he found:

Marijuana, in its natural form, is one of the safest therapeutically active substances known to man. It would be unreasonable, arbitrary and capricious for the DEA to continue to stand between those sufferers and the benefits of this substance.¹²

Judge Young’s findings of fact addressed each of the three Schedule I prongs: (1) high potential for abuse, (2) no currently accepted medical use in treatment in the United States, and (3) lack of accepted safety for use under medical supervision. He determined that the scientific evidence—drawn from FDA, NIDA, and independent researchers—demonstrated accepted medical uses for nausea, vomiting, appetite stimulation, and pain management, particularly in cancer and AIDS patients. Safety data showed marijuana’s therapeutic index to be extraordinarily high, with no documented lethal dose in humans and minimal physical dependence liability compared to opioids or alcohol.¹³

Although DEA Administrator John C. Lawn ultimately overruled the recommendation in 1989,¹⁴ Judge Young’s opinion remains the most thorough judicial-style analysis ever conducted within the agency itself. Carl Eric Olsen’s participation as a named petitioner in Docket No. 86-22 is explicitly noted in the appearances section and throughout the procedural history.¹⁵ Olsen’s subsequent decades of litigation in Iowa—pursuing both medical and religious-use arguments—kept the intellectual lineage alive when many assumed the issue had been settled.¹⁶

Michigan’s Schedule I Dismissals and the Cross-Pollination of Legal Strategy

That lineage reached Michigan in the early post-MMMA era. According to reported accounts in professional biographies and contemporary news coverage, in People v. Richmond (Oakland County Circuit Court, Jan. 2012), defense counsel Neil Rockind secured dismissal of all felony charges against operators of the Clinical Relief Medical Marijuana Dispensary.¹⁷ Similar “Sulaka-style” challenges yielded dismissals on equal-protection and statutory-construction grounds.¹⁸

While no publicly available media interview has surfaced in which Mr. Rockind expressly credits Iowa and Carl Olsen for the Schedule I nullification theory, the factual record includes direct personal communication. Following the Richmond dismissal, Mr. Rockind contacted this author by telephone, provided his personal cell number, and stated that—while he does not ordinarily represent clients outside Michigan—he viewed the Iowa work as an exception worthy of collaboration. He verbally acknowledged having adapted the Schedule I argument directly from the legal strategy developed in Iowa, which this author had refined in partnership and under the tutelage of Carl Olsen.¹⁹

This transmission of doctrine—from Judge Young’s 1988 findings, through Olsen’s persistent petitions, to Iowa administrative and judicial filings developed by this author in partnership and under the tutelage of Carl Olsen, and ultimately to successful Michigan trial-court dismissals—illustrates how a single administrative-law judge’s recommended ruling can seed constitutional and statutory challenges across decades and jurisdictions.

South Dakota’s Schedule I Marijuana Prohibition Heads to Court This Summer: Lawsuit Will Seek Declaration That State Law No Longer Satisfies Its Own Criteria

Implications for the Current Rescheduling Moment

The April 2026 federal action does not automatically deschedule marijuana or grant religious exemptions; it merely moves certain FDA-approved and state-licensed medical products to Schedule III. Yet the state-level statutory triggers documented herein will force dozens of legislatures and agencies to confront the same questions Judge Young answered thirty-eight years ago. South Carolina’s automatic mechanism and Tennessee’s defensive legislation represent opposite poles of the same phenomenon: the CSA’s cooperative-federalism architecture is no longer dormant.

WeedPress has maintained a “Paper Trail” methodology precisely to equip practitioners, legislators, and courts with primary-source documentation of these dynamics. The 2024 prediction was not advocacy; it was statutory cartography. Events in Columbia and Nashville now confirm its accuracy.

As more states navigate the post-rescheduling landscape, the historical record—from Docket No. 86-22 to the Michigan dismissals—remains essential reading. The safest therapeutically active substance known to man, in Judge Young’s words, continues to test the boundaries of federalism, equal protection, and administrative rationality.

Footnotes

¹ Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III, 91 Fed. Reg. 22714 (Apr. 28, 2026) (final rule); see also Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana in Schedule III, U.S. Dep’t of Justice (Apr. 23, 2026), https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana.

² Jason Karimi, 27 States Will Automatically Reschedule Cannabis Once The Feds Reschedule, WeedPress.org (Dec. 16, 2024), https://weedpress.org/2024/12/16/27-states-will-automatically-reschedule-cannabis-once-the-feds-reschedule/.

³ S.C. Code Ann. § 44-53-160(C) (2023).

⁴ South Carolina Patients Could Get Medical Marijuana Access Under State Laws Triggered By Federal Rescheduling, Marijuana Moment (Apr. 29, 2026), https://www.marijuanamoment.net/south-carolina-patients-could-get-medical-marijuana-access-under-state-laws-triggered-by-federal-rescheduling/.

⁵ Id. (quoting Gov. McMaster’s office).

⁶ Tenn. Code Ann. § 39-17-403 (as amended by SB 1603, 2026).

⁷ Tennessee Governor Signs Bill Blocking State Medical Marijuana Legalization Review Following Federal Rescheduling, Marijuana Moment (Apr. 27, 2026), https://www.marijuanamoment.net/tennessee-governor-signs-bill-blocking-state-medical-marijuana-legalization-review-following-federal-rescheduling/.

⁸ Karimi, supra note 2.

⁹ Id. (listing Alaska, Arizona, California, Colorado, Connecticut, Hawaii, Kansas, Maine, and twenty others).

¹⁰ In re Marijuana Rescheduling Petition, DEA Docket No. 86-22 (Op. & Recommended Ruling of ALJ Francis L. Young, Sept. 6, 1988) [hereinafter Young Opinion].

¹¹ Id.; see also 54 Fed. Reg. 53,767 (Dec. 29, 1989) (final denial).

¹² Young Opinion at 57–58 (verbatim).

¹³ Id. at 16–69 (Findings of Fact §§ 1–200+).

¹⁴ 54 Fed. Reg. 53,767 (Dec. 29, 1989) (denial).

¹⁵ Young Opinion, Appearances § (listing “Carl Eric Olsen, Pro Se”).

¹⁶ See, e.g., Olsen v. DEA, 776 F.2d 267 (11th Cir. 1985).

¹⁷ Neil Rockind professional biography, Super Lawyers (noting State of Michigan v. Ryan Richmond a/k/a Clinical Relief Medical Marijuana Dispensary Case: dismissal of all charges, Jan. 2012); see also Metro Times coverage (Jan. 2012).

¹⁸ People v. Sulaka (Macomb County Circuit Court, early 2010s dismissal on Schedule I/equal-protection grounds) (reported in professional profiles).

¹⁹ Direct telephone communication with Neil Rockind, post-January 2012 Richmond dismissal (personal cell number provided; explicit attribution to Iowa/Olsen strategy acknowledged).

WeedPress: The Paper Trail continues. Primary sources, statutory text, and judicial records remain the only reliable map through the rescheduling thicket.